|
KIF20A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.86919999875823E-08 |
| Normal-vs-Stage2 |
9.979900E-02 |
| Normal-vs-Stage3 |
2.32339999999276E-05 |
| Normal-vs-Stage4 |
2.132200E-02 |
| Stage1-vs-Stage2 |
6.360000E-01 |
| Stage1-vs-Stage3 |
6.218900E-04 |
| Stage1-vs-Stage4 |
5.309600E-02 |
| Stage2-vs-Stage3 |
1.828400E-02 |
| Stage2-vs-Stage4 |
8.954200E-02 |
| Stage3-vs-Stage4 |
6.892400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.32391883514538E-12 |
| Normal-vs-AfricanAmerican |
3.440200E-04 |
| Normal-vs-Asian |
2.215700E-02 |
| Caucasian-vs-AfricanAmerican |
5.529400E-01 |
| Caucasian-vs-Asian |
1.276650E-01 |
| AfricanAmerican-vs-Asian |
7.197600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.49644749317213E-12 |
| Normal-vs-Female |
1.10620000004502E-06 |
| Male-vs-Female |
6.357900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.241000E-03 |
| Normal-vs-Extreme_Weight |
1.03320000000018E-07 |
| Normal-vs-Obese |
4.67319999997162E-06 |
| Normal-vs-Extreme_Obese |
2.787700E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.172810E-01 |
| Normal_Weight-vs-Obese |
9.440800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.272160E-02 |
| Extreme_Weight-vs-Obese |
4.088300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.140100E-02 |
| Obese-vs-Extreme_Obese |
9.418900E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.582600E-03 |
| Normal-vs-Age(41-60Yrs) |
5.11489994803327E-09 |
| Normal-vs-Age(61-80Yrs) |
1.73150000004618E-07 |
| Normal-vs-Age(81-100Yrs) |
5.798300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.033780E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.722000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.107800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.619700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.243800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.121800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.53415083256914E-13 |
| Normal-VS-Type2 PRCC |
3.72209999999207E-06 |
| Normal-VS-KIRP CIMP |
2.082000E-03 |
| Normal-VS-Unclassified PRCC |
1.117050E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.738300E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.285000E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
9.530200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.836500E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
3.425400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.963000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.029790E-04 |
| Normal-vs-N1 |
1.61244999999921E-05 |
| Normal-vs-N2 |
8.198100E-02 |
| N0-vs-N1 |
1.377900E-03 |
| N0-vs-N2 |
2.834600E-01 |
| N1-vs-N2 |
3.997000E-01 |
|
|
